Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients

June 6, 2018

Tenax Therapeutics, Inc. (TENX), a specialty pharmaceutical company focused on providing products to address conditions with significant unmet medical needs, today announced the registration of their Phase 2 clinical trial in the use of levosimendan for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF) on ClinicalTrials.gov.

The Phase 2 PH-HFpEF study is a multi-center, double blind, randomized, placebo-controlled clinical trial that is testing the hypothesis that chronic, intermittent doses of levosimendan will significantly improve hemodynamic measures of exercise performance in patients suffering from Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction. PH-HFpEF patients will be enrolled at a targeted 20-25 sites, in an open-label lead-in phase of the study. Subjects who have responded positively to the first hospital-administered dose of levosimendan will be randomized in the study and receive levosimendan or placebo for four additional weekly treatments. The study is expected to be initiated in the third quarter.

“We are very pleased to begin this new Phase 2 study, which has been designed in collaboration with - leading pulmonary hypertension and HFpEF experts to efficiently evaluate the effectiveness of levosimendan in this patient population,” said Michael Jebsen, Interim CEO of Tenax. “The estimated prevalence of PH-HFpEF in the US is high, with some estimates exceeding 1.5 million patients. PH-HFpEF patients have increased mortality and morbidity, as well as suffer from reduced exercise capacity and quality of life. There are no drugs approved to treat this condition. If levosimendan can improve their hemodynamic function, the improvements in their quality of life could be significant.”

For more information, visit www.tenaxthera.com.

 

See the latest posts on our homepage


Share

Topic Area: Press Release


Recent Posts
Recent Posts

C. difficile strain evolving to live in hospital rooms


A subset of Clostridium difficile bacteria is on the verge of becoming a new species

8/23/2019

Tips for energy efficient healthcare facilities


Improving energy efficiency can be done in a few minutes a day

8/23/2019

Security catches woman trying to kidnap toddler from N.Y. hospital


The suspect allegedly took a stroller with a two-year-old inside and fled St. Joseph’s Hospital

8/23/2019

Rhode Island hospital employees to get panic buttons


Contract with Our Lady of Fatima Hospital addresses concerns around safety

8/23/2019

Maintaining sidewalks and parking garages requires a comprehensive, strategic approach


By developing inspection guidelines for common causes of problems, managers can extend the performance life of concrete components

8/23/2019





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.